TRBC1 ADC

Clinical trials for TRBC1 ADC explained in plain language.

Never miss a new study

Get alerted when new TRBC1 ADC trials appear

Sign up with your email to follow new studies for TRBC1 ADC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can a smart drug spare healthy cells while killing lymphoma?

Disease control Not yet recruiting

This trial is testing an experimental drug called FG-M131 in people with a type of blood cancer called peripheral T-cell lymphoma that has come back or not responded to prior treatment. FG-M131 is designed to target and destroy cancerous T cells that carry a marker called TRBC1, …

Matched conditions: TRBC1 ADC

Phase: PHASE1, PHASE2 • Sponsor: FutureGen Biopharmaceutical (Beijing) Co., Ltd • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

TRBC1 ADC

Get alerted when new TRBC1 ADC trials appear

Can a smart drug spare healthy cells while killing lymphoma?